The mission of End Kids Cancer is to provide financial support for preclinical research and clinical trials that will cure neuroblastoma, with an emphasis on non-toxic treatments. This narrow focus on neuroblastoma is designed to increase the success of curing neuroblastoma. While the foundation’s focus is narrow, the benefits derived from advancements made in neuroblastoma will be broad. At the time of this writing, several other cancers will benefit from advancements made in neuroblastoma research. Some of the more commonly known are: breast cancer, lung cancer, brain cancer, liver cancer, skin cancer. The implications are significant. Our foundation’s secondary mission is to disseminate critical information we acquire while executing our primary mission.